I'm listening to Gilead's 1st Q conference call focusing on Remdesivir which, for now, is introduced to the patient intravenously. The CEO said it can't be used in pill form but they're looking into whether it could be given through some mist device, an inhaler. I'm sending Joe a note to make sure he's aware of this potential opportunity.